相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。When is Alzheimers not dementiauCochrane commentary on The National Institute on Ageing and Alzheimers Association Research Framework for Alzheimers Disease
Jenny McCleery et al.
AGE AND AGEING (2019)
Alzheimer disease and aducanumab: adjusting our approach
Dennis J. Selkoe
NATURE REVIEWS NEUROLOGY (2019)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Investigational BACE inhibitors for the treatment of Alzheimer's disease
Bruno P. Imbimbo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions
David R. Elmaleh et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial
Daniel K. Burns et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis
Bing Cao et al.
DIABETES OBESITY & METABOLISM (2018)
Mitochondria and Alzheimer's Disease: the Role of Mitochondrial Genetic Variation
Perry G. Ridge et al.
CURRENT GENETIC MEDICINE REPORTS (2018)
Effects of pioglitazone on the incidence of dementia in patients with diabetes
Ping-Song Chou et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
Helene-Marie Lanoiselee et al.
PLOS MEDICINE (2017)
Understanding the genetics of APOE and TOMM40 and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease
Allen Roses et al.
ALZHEIMERS & DEMENTIA (2016)
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Juan Carlos Corona et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Effect of pioglitazone medication on the incidence of dementia
Michael T. Heneka et al.
ANNALS OF NEUROLOGY (2015)
The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Using Genetics to Enable Studies on the Prevention of Alzheimer's Disease
D. G. Crenshaw et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
Bruno Vellas et al.
LANCET NEUROLOGY (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
David S. Geldmacher et al.
ARCHIVES OF NEUROLOGY (2011)
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Tomohiko Sato et al.
NEUROBIOLOGY OF AGING (2011)
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease
L. Mosconi et al.
NEUROLOGY (2009)
Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial
Steven T. DeKosky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
ADCS Prevention Instrument Project: Assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials
Douglas Galasko et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism
EM Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of mitochondrial dysfunction in Alzheimer's disease
R Castellani et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Declining brain activity in cognitively normal apolipoprotein E ε4 heterozygotes:: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
EM Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection
AM Saunders et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
分享论文
